Comparison of 2 third-generation drug-eluting stents

Results of DUTCH PEERS (TWENTE II) trial reported at TCT 2013 Results of the DUTCH PEERS (TWENTE II) clinical trial demonstrate comparable safety and efficacy of two third-generation permanent polymer-based drug-eluting stents with low rates of adverse clinical events and establish the non-inferiority of the newest zotarolimus-eluting stent. The findings were presented today at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium... via Health News from Medical News Today Read More Here..